Kimball, A.B. Jemec, G.B.E. Alavi, A. Reguiai, Z. Gottlieb, A.B. Bechara, F.G. Paul, C. Giamarellos Bourboulis, E.J. Villani, A.P. Schwinn, A. Ruëff, F. Pillay Ramaya, L. Reich, A. Lobo, I. Sinclair, R. Passeron, T. Martorell, A. Mendes-Bastos, P. Kokolakis, G. Becherel, P.-A. Wozniak, M.B. Martinez, A.L. Wei, X. Uhlmann, L. Passera, A. Keefe, D. Martin, R. Field, C. Chen, L. Vandemeulebroecke, M. Ravichandran, S. Muscianisi, E., Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials, The Lancet Neurology, (401), 747-761, 2023, Elsevier B.V.,